相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。PAX2 promoter methylation and AIB1 overexpression promote tamoxifen resistance in breast carcinoma patients
Rosa Jahangiri et al.
JOURNAL OF ONCOLOGY PHARMACY PRACTICE (2022)
Serum mitochondrial tsRNA serves as a novel biomarker for hepatocarcinoma diagnosis
Shoubin Zhan et al.
FRONTIERS OF MEDICINE (2022)
Connectivity Mapping Identifies BI-2536 as a Potential Drug to Treat Diabetic Kidney Disease
Lu Zhang et al.
DIABETES (2021)
Identification of prostate cancer specific methylation biomarkers from a multi-cancer analysis
Yiyi Pu et al.
BMC BIOINFORMATICS (2021)
Integrative pan cancer analysis reveals epigenomic variation in cancer type and cell specific chromatin domains
Lijin K. Gopi et al.
NATURE COMMUNICATIONS (2021)
An Insight into GPCR and G-Proteins as Cancer Drivers
Preeti Kumari Chaudhary et al.
CELLS (2021)
oncoPredict: an R package for predicting in vivo or cancer patient drug response and biomarkers from cell line screening data
Danielle Maeser et al.
BRIEFINGS IN BIOINFORMATICS (2021)
Differential methylation of G-protein coupled receptor signaling genes in gastrointestinal neuroendocrine tumors
Seyoun Byun et al.
SCIENTIFIC REPORTS (2021)
DNA methylation-based signature of CD8+tumor-infiltrating lymphocytes enables evaluation of immune response and prognosis in colorectal cancer
Qi Zou et al.
JOURNAL FOR IMMUNOTHERAPY OF CANCER (2021)
clusterProfiler 4.0: A universal enrichment tool for interpreting omics data
Tianzhi Wu et al.
INNOVATION (2021)
Pan-cancer analysis of differential DNA methylation patterns
Mai Shi et al.
BMC MEDICAL GENOMICS (2020)
Molecular chaperones and G protein-coupled receptor maturation and pharmacology
Ya-Xiong Tao
MOLECULAR AND CELLULAR ENDOCRINOLOGY (2020)
Integrative analysis identifies potential DNA methylation biomarkers for pan-cancer diagnosis and prognosis
Wubin Ding et al.
EPIGENETICS (2019)
GPCRs show widespread differential mRNA expression and frequent mutation and copy number variation in solid tumors
Krishna Sriram et al.
PLOS BIOLOGY (2019)
Cancer biomarker discovery and translation: proteomics and beyond
Ventzislava A. Hristova et al.
EXPERT REVIEW OF PROTEOMICS (2019)
Neoadjuvant plus adjuvant dabrafenib and trametinib versus standard of care in patients with high-risk, surgically resectable melanoma: a single-centre, open-label, randomised, phase 2 trial
Rodabe N. Amaria et al.
LANCET ONCOLOGY (2018)
GPCRomics: GPCR Expression in Cancer Cells and Tumors Identifies New, Potential Biomarkers and Therapeutic Targets
Paul A. Insel et al.
FRONTIERS IN PHARMACOLOGY (2018)
Matrix Metalloproteinase-9 (MMP-9) as a Cancer Biomarker and MMP-9 Biosensors: Recent Advances
Hao Huang
SENSORS (2018)
Dabrafenib plus Trametinib: a Review in Advanced Melanoma with a BRAF V600 Mutation
Sohita Dhillon
TARGETED ONCOLOGY (2016)
Cancer biomarker detection: recent achievements and challenges
Li Wu et al.
CHEMICAL SOCIETY REVIEWS (2015)
DNA methylation status is more reliable than gene expression at detecting cancer in prostate biopsy
A. Paziewska et al.
BRITISH JOURNAL OF CANCER (2014)
F2RL3 methylation in blood DNA is a strong predictor of mortality
Yan Zhang et al.
INTERNATIONAL JOURNAL OF EPIDEMIOLOGY (2014)
Effect of Selumetinib vs Chemotherapy on Progression-Free Survival in Uveal Melanoma A Randomized Clinical Trial
Richard D. Carvajal et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2014)
Therapeutic potential of β-arrestin- and G protein-biased agonists
Erin J. Whalen et al.
TRENDS IN MOLECULAR MEDICINE (2011)
Targeting DNA Methylation
Jean-Pierre J. Issa et al.
CLINICAL CANCER RESEARCH (2009)
Differential methylation of tissue- and cancer-specific CpG island shores distinguishes human induced pluripotent stem cells, embryonic stem cells and fibroblasts
Akiko Doi et al.
NATURE GENETICS (2009)
G-protein-coupled receptors and cancer
Robert T. Dorsam et al.
NATURE REVIEWS CANCER (2007)
The epigenetic progenitor origin of human cancer
AP Feinberg et al.
NATURE REVIEWS GENETICS (2006)